🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to determine the analgesic efficacy a...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2012-06
Trial ID
NCT01571362
This study will determine the relative abuse potential of intact and chewed...
Status
Completed
Location
Lifetree Clinical Research
Start Date
2013-11
Trial ID
NCT01986283
Treatments Being Tested
The main purpose of this study is to determine if oxycodone and naltrexone ...
Status
Completed
Location
INC Research Toronto Inc.
Start Date
2013-02
Trial ID
NCT01775189
The purpose of this study is to test in patients who have had hip replaceme...
Status
Terminated
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00364533
Treatments Being Tested
The purpose of this trial is to evaluate the effectiveness (level of pain c...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00421928
Treatments Being Tested
Opioids are frequently prescribed for chronic low back pain (CLBP). Psychia...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2009-02
Trial ID
NCT01502644
This study will determine whether treatment with an extended-release opioid...
Status
Terminated
Location
University of Rochester Medical Center
Start Date
2007-01
Trial ID
NCT00414453
The purpose of this study is to determine the analgesic efficacy of Egalet-...
Status
Completed
Location
Site 207
Start Date
2016-03
Trial ID
NCT02716857
Treatments Being Tested
The purpose of this study is to compare the subjective and objective effect...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00955110
Treatments Being Tested
This is a Phase 2 study, involving a 4-week treatment period, designed to t...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-06
Trial ID
NCT01366014